Interdonor variability of platelet response to thrombin receptor activation:: influence of PlA2 polymorphism

被引:65
|
作者
Lasne, D
Krenn, M
Pingault, V
Arnaud, E
Fiessinger, JN
Aiach, M
Rendu, F
机构
[1] Hop Broussais, Hemostase Lab, F-75674 Paris 14, France
[2] Fac Pharm, INSERM U428, Paris, France
[3] Hop Broussais, Ctr Rech Malad Vasc Peripher, Assoc Claude Bernard, F-75674 Paris 14, France
关键词
thrombin receptor; platelet; TRAP; Pl(A2) polymorphism; GPIIIa;
D O I
10.1046/j.1365-2141.1997.4973300.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Considering that platelet response to thrombin receptor activation might be critical for the development of arterial thrombosis, we measured the dense granule release under stimulation by the thrombin receptor activating peptide (TRAP) in a series of 102 healthy volunteers. The threshold TRAP concentration which initiated a secretion ranged from 3 to 20 mu M. A good concordance (79%, k=0.677) between two tests performed at a 1 month interval indicated that platelet response to thrombin receptor activation was characteristic of each individual donor. Since the threshold concentration required to initiate secretion corresponded to the threshold concentration which induced a biphasic aggregation, all volunteers were genotyped for the pl(A2) polymorphism, the Pro(33) variant of GPIIIa. Platelets from subjects with the Pl(A2) polymorphism required higher TRAP concentrations to aggregate than those from subjects with no pl(A2) allele (P=0.0012). However, they also required a higher ADP concentration to aggregate. In order to exclude any influence of GPIIIa polymorphism on TRAP-induced secretion, we studied the variability of platelet response to TRAP among the 77 individuals with no pl(A2) allele, and found the same interdonor variability with the same distribution of threshold TRAP concentrations as for the 102 individuals. The results suggest that (i) platelet secretion in response to thrombin receptor activation could be a genetically controlled phenotype independent of the GPIIIa polymorphism; (ii) the Pl(A2) polymorphism is associated with platelet hypoaggregability.
引用
收藏
页码:801 / 807
页数:7
相关论文
共 50 条
  • [1] Interdonor variability of platelet response to thrombin receptor activation, influence of PIA2 polymorphism
    Lasne, D
    Krenn, M
    Pingault, V
    Arnaud, E
    Fiessinger, JN
    Aiach, M
    Rendu, F
    THROMBOSIS AND HAEMOSTASIS, 1997, : O2466 - O2466
  • [2] PlA1/PlA2 polymorphism of platelet GPIIIa receptor and microangiopathy in type 1 diabetes
    Pucci, L
    Nannipieri, M
    Bandinelli, S
    Pilo, M
    Rizzo, L
    Zerbini, G
    Mangili, R
    Penno, G
    DIABETES, 1998, 47 : A130 - A130
  • [3] Increased platelet aggregability associated with platelet GPIIIa PLA2 polymorphism
    Feng, DL
    Lindpaintner, K
    Larson, MG
    ODonnell, CJ
    Lipinska, I
    Schmitz, C
    Sutherland, P
    Muller, JE
    Levy, D
    Tofler, GH
    CIRCULATION, 1997, 96 (08) : 2301 - 2301
  • [4] PlA1/PlA2 polymorphism of platelet GPIIIa receptor and microangiopathy in type 1 diabetic patients
    Pucci, L
    Nannipieri, M
    Bandinelli, S
    Pilo, M
    Mangili, R
    Navalesi, R
    Penno, G
    DIABETOLOGIA, 1998, 41 : A296 - A296
  • [5] Platelet PlA2 polymorphism and platelet activation are associated with increased troponin I release after cardiopulmonary bypass
    Rinder, CS
    Mathew, JP
    Rinder, HM
    Howe, JG
    Fontes, M
    Crouch, J
    Pfau, S
    Patel, P
    Smith, BR
    ANESTHESIOLOGY, 2002, 97 (05) : 1118 - 1122
  • [6] Platelet glycoprotein receptor IIIa polymorphism PlA1/PlA2 and coronary risk:: a meta-analysis
    Di Castelnuovo, A
    de Gaetano, G
    Donati, MB
    Iacoviello, L
    THROMBOSIS AND HAEMOSTASIS, 2001, 85 (04) : 626 - 633
  • [7] Coronary thrombosis and the platelet glycoprotein IIIA gene PLA2 polymorphism
    Durante-Mangoni, E
    Davies, GJ
    Ahmed, N
    Ruggiero, G
    Tuddenham, EG
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (02) : 218 - 219
  • [8] The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction
    Grove, EL
    Orntoft, TF
    Lassen, JF
    Jensen, HK
    Kristensen, SD
    JOURNAL OF INTERNAL MEDICINE, 2004, 255 (06) : 637 - 644
  • [9] PlA2 polymorphism and efficacy of aspirin
    Cooke, GE
    Bray, PF
    Hamlington, JD
    Pham, DM
    Goldschmidt-Clermont, PJ
    LANCET, 1998, 351 (9111): : 1253 - 1253
  • [10] Platelet PlA2 polymorphism and thromboembolic events: From inherited risk to pharmacogenetics
    Goldschmidt-Clermont, PJ
    Roos, CM
    Cooke, GE
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1999, 8 (02) : 89 - 103